Ortivus AB (publ) (STO:ORTI.B)
Sweden
· Delayed Price · Currency is SEK 1.305
-0.035 (-2.61%)
May 12, 2025, 3:24 PM CET
Ortivus AB Revenue
Ortivus AB had revenue of 18.14M SEK in the quarter ending March 31, 2025, a decrease of -17.73%. This brings the company's revenue in the last twelve months to 76.50M, down -2.10% year-over-year. In the year 2024, Ortivus AB had annual revenue of 80.41M, down -4.36%.
Revenue (ttm)
76.50M
Revenue Growth
-2.10%
P/S Ratio
0.82
Revenue / Employee
2.39M
Employees
32
Market Cap
62.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.41M | -3.67M | -4.36% |
| Dec 31, 2023 | 84.08M | -20.43M | -19.55% |
| Dec 31, 2022 | 104.51M | 10.24M | 10.86% |
| Dec 31, 2021 | 94.27M | -13.31M | -12.37% |
| Dec 31, 2020 | 107.58M | 56.73M | 111.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |